ORPHA:391351
SURF1-related Charcot-Marie-Tooth disease type 4
Also known as: CMT4K · Charcot-Marie-Tooth disease type 4K · SURF1-related CMT4 · SURF1-related severe demyelinating Charcot-Marie-Tooth disease
Publications
18
33.9th percentile
Trials
0
Interventional, condition-specific
Researchers
150
Distinct authors in sample
Gene link
SURF1
Strong
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A form of Charcot-Marie-Tooth disease type 4 characterized by childhood onset of severe, , demyelinating sensorimotor manifesting with distal muscle weakness and atrophy of hands and feet, distal sensory impairment (vibration and pinprick) of lower limbs, areflexia, severely reduced motor nerve conduction velocities (25 m/s or less), and lactic with complex IV deficiency. Patients may also present kyphoscoliosis, nystagmus, hearing loss, cerebellar and/or brain MRI abnormalities (putaminal and periaqueductal lesions).
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0014733
- OMIM:616684
- UMLS:C4225246
Additional Mondo synonyms (3)
Charcot-Marie-Tooth disease type 4 caused by mutation in SURF1 · Charcot-Marie-Tooth disease, type 4k · SURF1 Charcot-Marie-Tooth disease type 4
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.
- Gene identifiedPresent
Strong — SURF1
- LiteraturePresent
18 matched papers (16 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (SURF1).
GenCC classification: Strong.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
18
18 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
18 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
16 in the last 10 years · high confidence · 33.9th percentile (publications denominator)
Phrase hits: 18 · MeSH hits: 0
Who's working on it?
150
Distinct author names in 18 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Wang J2 papers · 2021
Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Papers in Europe PMC - 02Zeviani M2 papers · 2022
Department of Neurosciences, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
Papers in Europe PMC - 03Abreu L1 paper · 2018
Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, USA.
Papers in Europe PMC - 04Aleman A1 paper · 2023
Divisions of Neurology, The Hospital for Sick Children, Toronto, ON, Canada.
Papers in Europe PMC - 05Alston V1 paper · 2020
School of Fisheries, Aquaculture and Aquatic Sciences, Auburn University, Auburn, AL, United States.
Papers in Europe PMC - 06Amburgey K1 paper · 2023
Divisions of Neurology, The Hospital for Sick Children, Toronto, ON, Canada.
Papers in Europe PMC - 07Ando M1 paper · 2022
Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima City, Kagoshima, 890-8520, Japan.
Papers in Europe PMC - 08Ata H1 paper · 2022
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Papers in Europe PMC - 09Backenstose NJC1 paper · 2020
School of Fisheries, Aquaculture and Aquatic Sciences, Auburn University, Auburn, AL, United States.
Papers in Europe PMC - 10Bangs M1 paper · 2020
School of Fisheries, Aquaculture and Aquatic Sciences, Auburn University, Auburn, AL, United States.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name. 1 observational study did — shown below because natural-history and cohort work can be an important step toward a trial.
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
Broader category Charcot-Marie-Tooth disease type 4 also has no matched interventional trial. See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Broader category: Charcot-Marie-Tooth disease type 4
0
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Parent-category matching found a broader label but no interventional trials under it. How we count trials.
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"SURF1-related Charcot-Marie-Tooth disease type 4" OR "CMT4K" OR "Charcot-Marie-Tooth disease type 4K" OR "SURF1-related CMT4" OR "SURF1-related severe demyelinating Charcot-Marie-Tooth disease" OR "Charcot-Marie-Tooth disease type 4 caused by mutation in SURF1" OR "Charcot-Marie-Tooth disease, type 4k" OR "SURF1 Charcot-Marie-Tooth disease type 4"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"SURF1-related Charcot-Marie-Tooth disease type 4" OR "CMT4K" OR "Charcot-Marie-Tooth disease type 4K" OR "SURF1-related CMT4" OR "SURF1-related severe demyelinating Charcot-Marie-Tooth disease" OR "Charcot-Marie-Tooth disease type 4 caused by mutation in SURF1" OR "Charcot-Marie-Tooth disease, type 4k" OR "SURF1 Charcot-Marie-Tooth disease type 4" OR "SURF1"
Recall-expansion terms: SURF1
Study-type breakdown: 0 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"Charcot-Marie-Tooth disease type 4"
Query health: ok — strategies attempted: phrase, recall-expansion; with hits: phrase, recall-expansion
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T15:03:16.749Z